MASI Stock Analysis: Buy, Sell, or Hold?
MASI - Masimo Corporation
$178.81
0.17 (0.10%)
▲
5d:
+0.19%
30d:
+0.06%
90d:
+2.03%
HOLD
MODERATE Confidence
Analysis Updated: May 22, 2026 12:00 AM ET
Earnings: May 26, 2026
TODAY
Get Alerted When MASI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MASI is fairly valued with market pricing in 1.1% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: MASI is fairly valued with market pricing in 1.1% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$236.63
Based on 7.5% avg growth
INTRINSIC VALUE TODAY
$146.93
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MASI is currently trading at $178.81, which is considered extended relative to its 30-day fair value range of $178.36 to $178.66. The stock's valuation (Forward PE: 27.1) is in line with its historical norms (26.2). At these levels, the market is pricing in 1.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MASI is in a strong uptrend. The price is currently testing key support at $178.28. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MASI is in a strong uptrend. The price is currently testing key support at $178.28. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$178.36 -
$178.66
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.1%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($180.00)
- NEUTRAL: Market pricing in 1.1% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$178.36 -
$178.66
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$178.28
Resistance Level
$178.94
Current Trend
Strong Uptrend
Technical data as of
May 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
27.09
Wall Street Target
$180.00
(+0.7%)
Revenue Growth (YoY)
8.5%
Earnings Growth (YoY)
214.4%
Profit Margin
4.9%
Valuation Premium vs History
+1.1% premium
PE vs Historical
27.1 vs 26.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.1%
(market-implied from PE analysis)
1-Year Target
$180.78
(+1%)
2-Year Target
$182.77
(+2%)
3-Year Target
$184.78
(+3%)
3-Yr Target (if PE normalizes)
(PE: 27→26)
PE COMPRESSION
$178.74
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 27.1, Growth: 11.0%)
$244.24
(+37%)
Base:
(SPY PE: 22.0, Growth: 11.0%)
$198.29
(+11%)
Bear:
(PE: 18.7, Growth: 11.0%)
$168.55
(-6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (44x PE), but valuation improves significantly next year (27x PE) as earnings recover.
Trailing PE: 44.22 | Current EPS (TTM): $4.04
Bull Case
$321.10
(+80%)
Analyst growth 63.4%, PE expands to 48.6
Base Case
$291.91
(+63%)
Market implied 63.4%, PE stable at 44.2
Bear Case
$121.48
(-32%)
Severe decline -20.0%, PE contracts to 37.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 25, 2026 8:53 AM ET
Data refreshes hourly during market hours. Next update: 9:53 AM
Data refreshes hourly during market hours. Next update: 9:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MASI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$82 | 64 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 57 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$107 | 62 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$247 | 59 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 67 BUY |
